• Picard Medical filed a Form 12b-25, delaying its Form 10-Q for the quarter ended June 30, 2026.
• Management needs more time to review equity transactions, including warrant exchange fair value adjustments, reverse split recalculations, disclosures.
• Filing is expected within the SEC’s five-calendar-day extension period.
• No significant change in results of operations is anticipated versus the prior-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028093), on August 17, 2026, and is solely responsible for the information contained therein.